Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

150 kHz electromagnetic radiation might help improve PCOS in rats.